Compared with mice with mutated hKRAS, the EGFR (Del19) mice showed a much lower cancer burden and a longer process from initiation to early development of adenocarcinoma,80,81 which is conducive to observing the occurrence of carcinoma and evaluating the safety of MSCs in tumorigenesis. This evidence concerns the gene EGFR and carcinoma.